Showing results (821-830 of 996) with videos related to
Sort By:
Pageof 100
JCO Oncology Practice|January 11, 2024
Financial Toxicity and Health-Related Quality of Life Profile of Patients With Hematologic Malignancies Treated in a Universal Health Care SystemFrancesco Sparano, Johannes M Giesinger, Gianluca Gaidano, et al.British Journal of Haematology|April 11, 2016
Central nervous system involvement in AIDS-related lymphomasStefan K Barta, Jitesh Joshi, Nicolas Mounier, et al.Seminars in Oncology|February 19, 2005
Efficacy and safety of liposomal anthracyclines in phase I/II clinical trialsDavid S Alberts, Franco M Muggia, James Carmichael, et al.Breast Cancer Research and Treatment|September 27, 2013
Phase I-II study of the farnesyl transferase inhibitor tipifarnib plus sequential weekly paclitaxel and doxorubicin-cyclophosphamide in HER2/neu-negative inflammatory carcinoma and non-inflammatory estrogen receptor-positive breast carcinomaEleni Andreopoulou, Ivette S Vigoda, Vicente Valero, et al.Journal of Family Psychology : JFP : Journal of the Division of Family Psychology of the American Psychological Association (Division 43)|November 8, 2016
Latino parent acculturation stress: Longitudinal effects on family functioning and youth emotional and behavioral healthElma I Lorenzo-Blanco, Alan Meca, Jennifer B Unger, et al.Breast Cancer Research and Treatment|December 28, 2011
Phase I-II study of vorinostat plus paclitaxel and bevacizumab in metastatic breast cancer: evidence for vorinostat-induced tubulin acetylation and Hsp90 inhibition in vivoB Ramaswamy, W Fiskus, B Cohen, et al.Haematologica|August 24, 2014
A new prognostic score for AIDS-related lymphomas in the rituximab-eraStefan K Barta, Xiaonan Xue, Dan Wang, et al.Journal of the National Cancer Institute|June 5, 2014
Tumor microenvironment of metastasis and risk of distant metastasis of breast cancerThomas E Rohan, Xiaonan Xue, Hung-Mo Lin, et al.NPJ Breast Cancer|March 2, 2023
TGFβ-mediated MMP13 secretion drives myoepithelial cell dependent breast cancer progressionShayin V Gibson, Elena Tomas Bort, Lucía Rodríguez-Fernández, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 2, 2015
Clinical and Translational Results of a Phase II, Randomized Trial of an Anti-IGF-1R (Cixutumumab) in Women with Breast Cancer That Progressed on Endocrine TherapyWilliam J Gradishar, Denise A Yardley, Rachel Layman, et al.Pageof 100